EP3004171

METHODS FOR INHIBITING ATHEROSCLEROSIS BY ADMINISTERING AN INHIBITOR OF PCSK9

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    6.6.2014
  • EP published:
    13.10.2021
  • EP application number:
    14737087.8
  • Max expiry date:
    5.6.2034
  • Title:
    METHODS FOR INHIBITING ATHEROSCLEROSIS BY ADMINISTERING AN INHIBITOR OF PCSK9

Timeline

Today
6.6.2014EP application
13.10.2021EP Publication

Owner

  • Name:
    Regeneron Pharmaceuticals, Inc.
  • Address:
    777 Old Saw Mill River Road, Tarrytown, NY 10591-6707, US
  • Name:
    Sanofi Biotechnology
  • Address:
    54 rue La Boétie, 75008 Paris, FR

Inventor

  • Name:
    SASIELA, William J.
  • Address:
    Tarrytown, NY 10591-6706, US
  • Name:
    GUSAROVA, Viktoria
  • Address:
    Tarrytown, NY 10591-6706, US
  • Name:
    PEYMAN, Anusch
  • Address:
    D-65926 Frankfurt Am Main, DE
  • Name:
    SCHAEFER, Hans-ludwig
  • Address:
    D-65926 Frankfurt Am Main, DE
  • Name:
    SCHWAHN, Uwe
  • Address:
    D-65926 Frankfurt Am Main, DE

Priority

  • Number:
    201361832459 P
  • Date:
    7.6.2013
  • Country:
    US
  • Number:
    13305762
  • Date:
    7.6.2013
  • Country:
    EP
  • Number:
    201361892215 P
  • Date:
    17.10.2013
  • Country:
    US
  • Number:
    13306436
  • Date:
    18.10.2013
  • Country:
    EP
  • Number:
    201461944855 P
  • Date:
    26.2.2014
  • Country:
    US
  • Number:
    201462002508 P
  • Date:
    23.5.2014
  • Country:
    US

Classification

  • Categories:
    C07K 16/40, A61K 39/00

Upload documents